The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
Clinical observations on the therapeutic effect of urinaryKallindinogenase and edaravone in treatment of recurrent cerebral infarction in Acute stage
Pages: 48-49
Year: Issue:  12
Journal: Chinese Journal of Practical Nervous Diseases

Abstract: Objective To study the effect of UrinaryKallidinogenasecombined for injection with edaravone for injection in treatment of acute cerebral infarction.Methods Patients (92 cases) with acute cerebral infarction in hospital from Jan 2015 to Dec 2016 were randomly divided into control and treatment groups according to the extraction method,and control group had 46 cases,treatment groupshad 42 cases.Patients in the control group were iv administered with edaravone for injection,30mg,two times daily.The patients in treatment group wereiv administered with UrinaryKallidinogenase for injection,0.15 PNA Unit,once daily.The patients in two groups were treated for 21 d.After treatment,ability of daily life (ADL) score,and nerve function score in two groups were observed in two groups during the process of treatment was evaluated.Results After treatment,ADL scores in two groups were significantly increased,but nerve function scores in two groups were obviously decreased,and the difference was statistically significant in the same group (P<0.05).After treatment,the efficacies in the control and treatment groups were 76% and 85%,respectively,and there were differences between two groups (P<0.01).Conclusion UrinaryKallidinogenase combined with edaravone for injection has clinical curative effect in treatment of acute cerebral infarction,can significantly improve ability of daily life and nerve function.
Related Articles
No related articles found